As of Jan 20
| +0.25 / +0.41%|
The 3 analysts offering 12-month price forecasts for USANA Health Sciences Inc have a median target of 80.00, with a high estimate of 88.00 and a low estimate of 73.00. The median estimate represents a +29.66% increase from the last price of 61.70.
The current consensus among 3 polled investment analysts is to Buy stock in USANA Health Sciences Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.